ABT
Abbott Laboratories
- Stock buybacks, 2025
- $893M
- YoY, 2025
- −31.0%
- 5-year CAGR
- +17.2%
- 10-year CAGR
- −8.8%
Stock buybacks
Stock buybacks by fiscal year
| Period | Buybacks | YoY |
|---|---|---|
| 2025 | $893M | −31.0% |
| 2024 | $1.3B | +5.5% |
| 2023 | $1.2B | −67.7% |
| 2022 | $3.8B | +65.1% |
| 2021 | $2.3B | +470.5% |
| 2020 | $403M | −43.9% |
| 2019 | $718M | +201.7% |
| 2018 | $238M | +103.4% |
| 2017 | $117M | −77.6% |
| 2016 | $522M | −76.7% |
| 2015 | $2.2B | +1.9% |
| 2014 | $2.2B | +36.8% |
| 2013 | $1.6B | −32.1% |
| 2012 | $2.4B | +2,970.1% |
| 2011 | $77M | −91.1% |
| 2010 | $867M | +4.9% |
| 2009 | $826M | −23.6% |
| 2008 | $1.1B | +2.2% |
| 2007 | $1.1B | — |